Archive for the ‘Advanced Medical Isotope Corp. ADMD’ Category

Small Cap Voice Featured Company: Advanced Medical Isotope Corporation (ADMD.PK)

Thursday, March 19th, 2009

Advanced Medical Isotope Corporation (ADMD.PK) develops advanced production systems and processes in the nuclear medicine industry. The Company’s primary focus is on making previously unavailable medical isotopes, such as radioisotopes and stable isotopes, more available to the medical marketplace. In addition, the company leads the way to advanced systems for local product production. The company encourages using less invasive therapeutic processes, liked medical imaging, rather than highly invasive surgical approaches in the diagnosis and treatment of diseases like cancer.

Advanced Medical has the rights to an advanced design compact system. This system is used in a series of medical radioisotopes for the advancement of medical imaging diagnostics. Positron Emission Tomography, also known as PET scanning, or imaging, is a newer diagnostic imaging device. PET scans are used to identify, isolate and target cancerous growths. Using Advanced Medical’s isotopes reduces the process losses that occur when using isotopes produced in a university, or government, reactor. The company intends to develop a larger and more impressive portfolio of isotope products in order to offer more options to the medical industry.

Advanced Medical Isotope owns the Life Sciences Division of Isonics. Both companies saw the need to supply isotopes for use in life sciences applications. When chemically compounded, isotopes concentrate on specific parts of the body after an implantation, injection, inhalation, or ingestion. The most common application is cancer imaging and treatment.

Isotopes are incredibly vital tools in medicine and scientific research. The company reports that more than 12 million nuclear medicine procedures, like PET scans, are performed annually in the US, and that approximately one-third of all patients admitted to a hospital undergo at least one procedure that uses a medical isotope. With an aging population, these numbers are expected to increase.

Let us hear your thoughts: Advanced Medical Isotope Corporation Message Board

Stock Guru Featured Client: Advanced Medical Isotope Corporation (ADMD.PK)

Wednesday, March 19th, 2008

Advanced Medical Isotope Corporation (ADMD.PK) develops advanced production systems and processes in the nuclear medicine industry. The Company’s primary focus is on making previously unavailable medical isotopes, such as radioisotopes and stable isotopes, more available to the medical marketplace. In addition, the company leads the way to advanced systems for local product production. The company encourages using less invasive therapeutic processes, liked medical imaging, rather than highly invasive surgical approaches in the diagnosis and treatment of diseases like cancer.

Advanced Medical has the rights to an advanced design compact system. This system is used in a series of medical radioisotopes for the advancement of medical imaging diagnostics. Positron Emission Tomography, also known as PET scanning, or imaging, is a newer diagnostic imaging device. PET scans are used to identify, isolate and target cancerous growths. Using Advanced Medical’s isotopes reduces the process losses that occur when using isotopes produced in a university, or government, reactor. The company intends to develop a larger and more impressive portfolio of isotope products in order to offer more options to the medical industry.

Advanced Medical Isotope owns the Life Sciences Division of Isonics. Both companies saw the need to supply isotopes for use in life sciences applications. When chemically compounded, isotopes concentrate on specific parts of the body after an implantation, injection, inhalation, or ingestion. The most common application is cancer imaging and treatment.

Isotopes are incredibly vital tools in medicine and scientific research. The company reports that more than 12 million nuclear medicine procedures, like PET scans, are performed annually in the US, and that approximately one-third of all patients admitted to a hospital undergo at least one procedure that uses a medical isotope. With an aging population, these numbers are expected to increase.

Let us hear your thoughts: Advanced Medical Isotope Corp. Message Board

StockGuru Trade Alert: Profile Stock Advanced Medical Isotope (ADMD) Up $0.08 and More than 11% Since Last Thursday

Tuesday, March 11th, 2008

StockGuru Trade Alert: Profile Stock Advanced Medical Isotope (ADMD) Up $0.08 and More than 11% Since Last Thursday

On Thursday, ADMD Closed at $0.70, and with Today’s High So Far of $0.78, it is Up 11.43%!

View the StockGuru Profile for ADMD:

http://stockguru.com/profiles/admd/

StockGuru News: Advanced Medical Isotope Corporation (ADMD) Releases Chairman’s Message

Tuesday, February 5th, 2008

KENNEWICK, Wash., Feb. 5, 2008 — Advanced Medical Isotope Corporation, (AMIC), headquartered in Kennewick, Wa., has released the following Chairman’s Message to Shareholders:

Dear Shareholders:

What an exciting and dynamic year we experienced together in 2007! By every measure, 2007 was a year of considerable activity and advancement for your company.

During the past twelve months, your company has made significant strides towards its goal to capitalize on the significant growth in nuclear medicine, positioning itself by:

– purchasing the first linear accelerator located in North America specifically designed for the purpose of PET isotopes production, with expanded capability to produce other high demand isotopes.

– initiating construction of our Washington State isotope production center and processing laboratory, and signed our first supply contract with a regional medical center.

– completing a strategic acquisition of a competitive firm, thereby establishing our position as a marketplace supplier through international sales of the Oxygen-18 isotope.

– formalizing working relationships with three universities (SUNY Buffalo, Idaho State University, and University of Missouri) as well as with three U.S. national laboratories (Pacific Northwest National Laboratory, Los Alamos National Laboratory, and Lawrence Berkeley National Laboratory) engaged in isotope production and application research.

– licensing the intellectual property rights for an advanced neutron production device.

– initiating three international advanced technology collaborative development projects for production and isotopic separation capability to offer high-value products not available from other sources.

– initiating discussions for the construction later this year of regional PET isotope production centers in Los Angeles, California and Oahu, Hawaii.

– entering into formal negotiations for the creation of strategic relationships to produce and sell medical isotopes in Taiwan and China.

This year, in late March we will have the official opening of our Washington State production facility in conjunction with a medical isotope symposium.

The Cure Starts Here! Symposium is principally sponsored by Citizens for Medical Isotopes (http://www.medicalisotopes.org) and will highlight the research, education, production, diagnostics, and therapies for many maladies, with the primary focus on diagnostics and therapy for various cancers. Rev. Jesse Jackson as well as a senior researcher from the Albert Einstein College of Medicine (where HIV-infected cells have been targeted and killed with medical isotopes) will be among the dignitaries present and speaking at the event. For further information about attending, please contact The Maurer Group, (509) 783-4677.

Further, I am most proud of our talented and committed employees, consultants, and Board of Directors for assisting AMIC in leveraging our financial, human and scientific/technological resources. AMIC’s standard commitment to value with a strategic emphasis of cost-effective technological innovation while developing and extending long term client relationships built on trust and performance should translate to shareholder value. Our various agreements with national laboratories and universities complement our strategy by speeding the launch of a variety of different products. The long term demographic trends as well as our scientific team’s technological innovations favor our core product mix.

There are more than 15 million nuclear medicine procedures performed each year in the U.S. Approximately one-third of all patients admitted to U.S. hospitals undergo at least one medical procedure that employs the use of medical isotopes. Diagnostic radioisotopes are used for functional (as compared to anatomic) imaging of internal organs. Therapeutic isotopes are effective in treating cancer and other illnesses while substantially reducing the adverse side effects of chemotherapy or radiation. When radioisotopes are compounded with other chemicals to make a drug, they are termed radiopharmaceuticals.

Frost & Sullivan, market analysts, indicate the U.S. sales of diagnostic radiopharmaceuticals reached $1.69 billion in 2005 and are expected to rise to $3.52 billion by 2012. This forecast is based on the introduction of new products for cardiology and oncology and continued growth of PET imaging. Bio-Tech Systems, Inc., health industry analysts, project that the market for therapeutic radiopharmaceuticals would reach $1.9 billion by 2012, with accelerating growth thereafter.

Currently, the major PET radiopharmaceutical is F-18 FDG (fluorodeoxyglucose). FDG sales are projected to increase from $259 million in 2005 to $933 million by 2012. FDG distribution will continue to improve, allowing more widespread use of PET imaging in community hospitals (which is an AMIC target niche). With procedure volume increasing, PET is expected to become more profitable for providers as well as for suppliers of FDG.

In conclusion, while developing cost effective, disruptive new technologies as well as implementing superior delivery systems, I am confident that Advanced Medical Isotope Corporation will soon prove to be an innovative leader in our specialty and we will endeavor to deliver strong returns for our shareholders. We are truly a company that consists of people promoting elements of change.

James C. Katzaroff
Chairman and President
Advanced Medical Isotope Corporation

About AMIC

Advanced Medical Isotope Corporation is engaged in the development of advanced production systems and processes for bringing previously unavailable medical isotopes to the marketplace and advanced systems for local product production. The field of nuclear medicine has routinely utilized radioisotopes in the diagnosis of disease while new processes are being pioneered for the targeted treatment of diseases such as cancer in preference to surgical techniques. Advanced Medical Isotope Corporation products support the accessibility to these less invasive therapeutic processes by advancing systems for lower cost production and improving supply availability of medical isotopes to hospitals and clinical treatment centers. For more information, please visit http://www.isotopia.us

Forward-Looking Statements

Except for historical information contained herein, the matters set forth in this press release, such as statements relating to the company’s ability to drive technological developments and the acceptance and timing of product introductions, are forward-looking statements that are subject to risks and uncertainties, including but not limited to, timely developments and acceptance of new products, the impact of competitive products and pricing, the timely developments and release of products by suppliers, and other risks.

Contact:

Advanced Medical Isotope Corporation
James C. Katzaroff
(509) 736-4000
Fax: (509) 736-4004
www.isotopia.us

Source: Advanced Medical Isotope Corporation

StockGuru News: Advanced Medical Isotope (ADMD) and EastBridge Investment Group (EBIG)

Friday, October 26th, 2007

Advanced Medical Isotope Corporation (OTC: ADMD)

Marishka Pilch Joins Advanced Medical Isotope Corporation as International Marketing Director

KENNEWICK, Wash., Oct. 26, 2007 — Advanced Medical Isotope Corporation (AMIC) of Kennewick, WA today announced that Marishka Pilch will serve as International Marketing Director effective immediately. Pilch has extensive healthcare, sales and marketing experience. In 2004, she founded PET2Market (see http://www.pet2market.com), a consulting firm specializing in marketing and clinical education for PET (positron emission tomography) imaging centers. Prior positions for Pilch included marketing and customer support at Alliance Imaging, a national provider of diagnostic imaging services.

Read full release here:
http://stockguru.com/profiles/admd/news.php

EastBridge Investment Group Corporation (OTCBB: EBIG)

EastBridge Investment Group Taking Chinese Professional College Public

PHOENIX, AZ–Oct 26, 2007 — EastBridge Investment Group (EBIG) today announced that it has signed a definitive listing agreement to take Wenda Advanced Professional College Group in Anhui, China public in the United States. EastBridge will provide listing services to Wenda, a major regional professional college located just west of Shanghai, China, with the intent to list the company on the Nasdaq or American Stock Exchange as soon as practicable. It offers professional and vocational educational programs to train post high school students to improve their skills for higher paying jobs. Wenda offers programs mainly in the computer related IT sectors such as network design, hardware technology, computer graphics, CAD, animation, network database and network security

Read full release here:
http://stockguru.com/profiles/ebig/news.php

StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (469) 252-3030. Web: StockGuru.com. Email: Publisher@stockguru.com.  ADMD Disclosure: Pentony Enterprises LLC has been compensated five thousand dollars and one hundred thousand restricted shares directly from the company for profile coverage. EBIG Disclosure: Pentony Enterprises LLC was compensated 430,000 restricted shares directly from the company for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

StockGuru Blog: Advanced Medical Isotope Corporation (ADMD) – First in the U.S. and Joint Venture with SUNY Buffalo

Thursday, October 25th, 2007

Stock Guru OverviewNewsBlogs

Perhaps there is no single more important piece of information about this company than the fact that the officers and directors here have invested $2.7M of their own money in this company. This means you are their partner. It also means this company will be driven at light speed.

The second most important data that you need to know is that this company has a joint venture arrangement with SUNY Buffalo among other important collaborative efforts.

Isotopes are a growth business. This company is developing an efficient and smaller size equipment that every hospital can use to create their own isotopes. Currently, over ninety percent of medical isotopes are imported from other countries.

This company’s goal is to deliver U.S. isotopes to U.S. hospitals.

There is a definable market here and this is a boomer business that expands as boomers age. The creation and production of medical isotopes is going through the same kind of expansion computers experienced. Computers once the size of a small desk did not have the power a cell phone has. This is precisely what is happening in the isotope creation market!

Over twelve million nuclear medicine procedures are performed each year in the United States and they all require the use of isotopes.

The officers and directors here have invested $2.7M of their own money in this company. The miniaturization of this technology creates a fabulous opportunity for North America. This company has a Nuclear Physicist PhD on board and is guided by experienced business men. You have an opportunity as a shareholder to partner with these experts. MORE SOON!

Source: Advanced Medical Isotope Corporation http://www.advancedmedicalisotopes.com/

Advanced Medical Isotope Corporation
James C. Katzaroff
(509) 736-4000
7203 West Deschutes
Suite C
Kennewick, WA 99336
Phone: 509-736-7000
Fax: 509-736-7001

Advanced Medical Isotope Corporation is engaged in the development of advanced production systems and processes for bringing previously unabailable medical isotopes to the marketplace and advancing systems for local product production. The field of nuclear medicine has routinely utilized radioisotopes in the diagnosis of disease while new processes are being pioneered for the targeted treatment of diseases such as cancer in preference to surgical techniques. Advanced Medical Isotope Corporation products support the accessibility to these less invasive therapeutic processes by advancing systems for lower cost production and improving supply availability of medical isotopes to hospitals and clinical treatment centers. For more information, please visit

www.isotopia.us
Forward-Looking Statements: Except for historical information contained herein, the matters set forth in this press release, such as statements relating to the company’s ability to drive technological developments and the acceptance and timing of product introductions, are forward-looking statements that are subject to risks and uncertainties, including but not limited to, timely development and acceptance of new products, the impact of competitive products and pricing, the timely development and release of products by suppliers, and other risks.

Disclosure: Pentony Enterprises LLC has been compensated five thousand dollars and one hundred thousand restricted shares directly from the company for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com .

INDUSTRY KEYWORD: Medical Supplies SUBJECT CODE: MEDICAL ; HEALTH ; CONTRACTS

StockGuru Blog: Advanced Medical Isotope (ADMD) – The Big and Serious Business of Isotopes

Saturday, October 13th, 2007

Stock Guru OverviewNewsBlogs

Isotopes are big business. In a nutshell this is what you MUST KNOW about ISOTOPES!

Isotopes are important in medicine for:

  • Diagnosis,
  • Treatment, and
  • Research.

Over twelve million nuclear medicine procedures are performed each year in the United States and they all require the use of isotopes.

Roughly one-third of all patients admitted to U.S. hospitals undergo at least one medical procedure that employs the use of medical isotopes.

Imaging Internal Organs

Diagnostic radioisotopes are used for imaging internal organs.

Radioisotopes reveals organ function and structure.

This provides data for a more accurate diagnosis and early detection of abnormalities.

Therapeutic isotopes have proven effective in treating cancer and other illnesses by cell-directed localized radiation therapy.

This substantially reduces the adverse side effects of chemotherapy or radiation.

Current medical applications involve the diagnosis and treatment of three major disease classes:

  • Cancer,
  • Vascular Disease
  • Arthritis.

Government projections indicate the growth rate in medical isotope use will be significant over the next 20 years.

  • The US diagnostic radio pharmaceuticals market is expected to grow between 7% – 14% and range from $2.7 billion to $18.7 billion by 2020.
  • The therapeutic radio pharmaceutical market is expected to grow between 7% – 16% and range from $244 million to $1.11 billion by 2020.
  • Industry analysts project an aggressive growth predicting revenues at the high end of the federal estimates.

Source: Advanced Medical Isotope Corporation http://www.advancedmedicalisotopes.com/

Advanced Medical Isotope Corporation
James C. Katzaroff
(509) 736-4000
7203 West Deschutes
Suite C
Kennewick, WA 99336
Phone: 509-736-7000
Fax: 509-736-7001

Advanced Medical Isotope Corporation is engaged in the development of advanced production systems and processes for bringing previously unabailable medical isotopes to the marketplace and advancing systems for local product production. The field of nuclear medicine has routinely utilized radioisotopes in the diagnosis of disease while new processes are being pioneered for the targeted treatment of diseases such as cancer in preference to surgical techniques. Advanced Medical Isotope Corporation products support the accessibility to these less invasive therapeutic processes by advancing systems for lower cost production and improving supply availability of medical isotopes to hospitals and clinical treatment centers. For more information, please visit

www.isotopia.us
Forward-Looking Statements: Except for historical information contained herein, the matters set forth in this press release, such as statements relating to the company’s ability to drive technological developments and the acceptance and timing of product introductions, are forward-looking statements that are subject to risks and uncertainties, including but not limited to, timely development and acceptance of new products, the impact of competitive products and pricing, the timely development and release of products by suppliers, and other risks.

Disclosure: Pentony Enterprises LLC has been compensated five thousand dollars and one hundred thousand restricted shares directly from the company for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com .

INDUSTRY KEYWORD: Medical Supplies SUBJECT CODE: MEDICAL ; HEALTH ; CONTRACTS

StockGuru Profile: Advanced Medical Isotope Corporation (ADMD)

Thursday, October 11th, 2007

StockGuru Profile:

Advanced Medical Isotope Corporation (ADMD)

Advanced Medical Isotope Corporation (OTC: ADMD)

Advanced Medical Isotope Corporation is engaged in the development of advanced production systems and processes for bringing previously unavailable medical isotopes to the marketplace and advancing systems for local product production. The field of nuclear medicine has routinely utilized radioisotopes in the diagnosis of disease while new processes are being pioneered for the targeted treatment of diseases such as cancer in preference to surgical techniques. Advanced Medical Isotopes Corporation products support the accessibility to these less invasive therapeutic processes by advancing systems for lower cost production and improving supply availability of medical isotopes to hospitals and clinical treatment centers.

View the StockGuru Profile for Advanced Medical Isotope:

http://www.stockguru.com/profiles/admd/

StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (469) 252-3030. Web: StockGuru.com. Email: Publisher@stockguru.com. Disclosure: Pentony Enterprises LLC has been compensated five thousand dollars and one hundred thousand restricted shares directly from the company for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

StockGuru News: Advanced Medical Isotope (ADMD) and Etelcharge.com (ETLC)

Thursday, October 11th, 2007

Advanced Medical Isotope Corporation(OTC: ADMD)

Advanced Medical Isotope Corporation Finalizes Contract With Kadlec Medical Center

Stock Guru Profile  -   Blogs & Alerts  -  News & Quotes

KENNEWICK, Wash., Oct. 11, 2007 (PRIME NEWSWIRE) — Advanced Medical Isotope Corporation (AMIC) (Other OTC:ADMD.PK – News), pursuant to the Memorandum of Understanding signed in March, 2007, has finalized a sole-source contract with Kadlec Medical Center of Richland, Washington, for the supply of short-lived radioisotopes primarily used in Positron Emission Tomography(PET) as well as for other medical isotopes utilized for diagnostic imaging and for therapeutic applications.

Read full release here:

http://stockguru.com/profiles/admd/news.php

Etelcharge.com (OTCBB: ETLC)

Robyn Priest Appointed Chief Financial Officer

Company’s Finance Consultant Assumes Permanent Post

Stock Guru Profile  -   Blogs & Alerts  -  News & Quotes

DESOTO, TX–(MARKET WIRE)–Oct 11, 2007 — Etelcharge.com (OTC BB:ETLC.OB – News) (www.etelcharge.com), the new online way to pay(TM), today announced that Robyn Priest has been appointed Chief Financial Officer.

Read full release here:

http://stockguru.com/profiles/etlc/news.php

StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (469) 252-3030. Web: StockGuru.com. Email: Publisher@stockguru.com. ADMD Disclosure: Pentony Enterprises LLC has been compensated five thousand dollars and one hundred thousand restricted shares directly from the company for profile coverage. ETLC Disclosure: Pentony Enterprises LLC has been compensated up to $12,000 by StockPromoters.com Consultants, LLC for profile coverage, with promotional services provided by stockpromoters.com for stockguru.com. For more information on this visit http://www.StockPromoters.com. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

SmallCapVoice Client: Advanced Medical Isotope Corp. (ADMD)

Monday, January 1st, 2007

Advanced Medical Isotopes Corporation is engaged in the development of advanced production systems and processes for bringing previously unavailable medical isotopes to the marketplace and advancing systems for local product production. The field of nuclear medicine has routinely utilized radioisotopes in the diagnosis of disease while new processes are being pioneered for the targeted treatment of diseases such as cancer in preference to surgical techniques.

Advanced Medical Isotopes Corporation products support the accessibility to these less invasive therapeutic processes by advancing systems for lower cost production and improving supply availability of medical isotopes to hospitals and clinical treatment centers.

For more information, please visit: http://www.qualitystocks.net/partners.php?partnerid=scvoice